Undeniable need for ultrafast-acting insulin: The pediatric perspective

Journal of Diabetes Science and Technology

Volumn 6, Issue 4, 2012, Pages 797-801

  Cengiz, Eda ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Children; Closed loop; Diabetes; Hyperglycemia; Hypoglycemia; Insulin analog; Ultrafast acting insulin

Indexed keywords

ANTIDIABETIC AGENT; INSULIN ASPART; INSULIN DERIVATIVE; PIG INSULIN; SHORT ACTING INSULIN; ULTRAFAST ACTING INSULIN; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG ABSORPTION; GLYCEMIC CONTROL; HUMAN; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; INSULIN RELEASE; INSULIN TREATMENT; BLOOD; BLOOD GLUCOSE MONITORING; CHILD; ENDOCRINOLOGY; EVALUATION; HEALTH SERVICE; INSTRUMENTATION; METHODOLOGY; PEDIATRICS; REVIEW;

BLOOD GLUCOSE SELF-MONITORING; CHILD; DIABETES MELLITUS, TYPE 1; ENDOCRINOLOGY; HEALTH SERVICES NEEDS AND DEMAND; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN INFUSION SYSTEMS; INSULIN, SHORT-ACTING; PEDIATRICS;

EID: 84873147369     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600409     Document Type: Conference Paper

References (26)

1. NIDDK: http://diabetes.niddk.nih.gov/dm/pubs/statistics/index#1- youngpeople.
2. Heinemann L, Muchmore D. Ultrafast acting insulins: state of the art. J Diabetes Sci Technol 2012;6(4):728-42.
3. Frohnauer MK, Woodworth JR, Anderson JH. Graphical human insulin time-activity profiles using standardized definitions. Diabetes Technol Ther. 2001;3(3):419-29. (Pubitemid 33032552)
4. Amiel SA, Caprio S, Sherwin RS, Plewe G, Haymond MW, Tamborlane WV. Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism. J Clin Endocrinol Metab. 1991;72(2):277-82. (Pubitemid 21921688)
5. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. Diabetes Control and Complications Trial Research Group. J Pediatr. 1994;125(2):177-88.
6. Swan KL, Weinzimer SA, Dziura JD, Steil GM, Voskanyan GR, Steffen AT, Martin ML, Tamborlane WV. Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes. Diabetes Care. 2008;31(1):44-6. Epub 2007 Oct 1.
7. Swan KL, Dziura JD, Steil GM, Voskanyan GR, Sikes KA, Steffen AT, Martin ML, Tambolane WV, Weinzimer SA. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care. 2009;32(2):240-4. Epub 2008 Nov 18.
8. Schmid V, Hohberg C, Borchert M, Forst T, Pfützner A. Pilot study for assessment of optimal frequency for changing catheters in insulin pump therapy-trouble starts on day 3. J Diabetes Sci Technol. 2010;4(4):976-82.
9. Vaughn DE, Muchmore DB. Use of recombinant human hyaluronidase to accelerate rapid insulin analogue absorption: experience with subcutaneous injection and continuous infusion. Endocr Pract 2011;17:914-21.
10. Hompesch M, Muchmore DB, Morrow L, Vaughn DE. Accelerated insulin pharmacokinetics and improved postprandial glycemic control in patients with type 1 diabetes after coadministration of prandial insulins with hyaluronidase. Diabetes Care. 2011;34(3):666-8. Epub 2011 Jan 27.
11. Clausen TS, Kaastrup P, Stallknecht B. Effect of insulin catheter wear-time on subcutaneous adipose tissue blood flow and insulin absorption in humans. Diabetes Technol Ther. 2009;11(9):575-80.
12. Nguyen TM, Renukuntla VS, Heptulla RA. Mixing insulin aspart with detemir does not affect glucose excursion in children with type 1 diabetes. Diabetes Care. 2010;33(8):1750-2. Epub 2010 May 26.
13. Kaplan W, Rodriguez LM, Smith OE, Haymond MW, Heptulla RA. Effects of mixing glargine and short-acting insulin analogs on glucose control. Diabetes Care. 2004;27(11):2739-40. (Pubitemid 39441481)
14. Cengiz E, Tamborlane WV, Martin-Fredericksen M, Dziura J, Weinzimer SA. Early pharmacokinetic and pharmacodynamic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes. Diabetes Care. 2010;33(5):1009-12. Epub 2010 Feb 11.
15. Cengiz E, Swan KL, Tamborlane WV, Sherr JL, Martin M, Weinzimer SA. The alteration of aspart insulin pharmacodynamics when mixed with detemir insulin. Diabetes Care. 2012;35(4):690-2. Epub 2012 Feb 28.
16. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of selfmonitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care. 2001;24(11):1858-62. (Pubitemid 33716491)
17. Wood JR, Maahs DM, Miller KM, T1D Exchange Clinic Network. Most Youth with Type 1 Diabetes (T1D) Do Not Meet ISPAD Clinical Goals for HbA1c: the T1D Exchange Clinic Registry. Presented at: 37th Annual Meeting, International Society for Pediatric and Adolescent Diabetes, Miami Beach, FL, October 19-22, 2011.
18. O'Connell SM, Cooper MN, Bulsara MK, Davis EA, Jones TW. Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009. Diabetes Care. 2011;34(11):2379-80. Epub 2011 Sep 16.
19. Amiel SA, Sherwin RS, Simonson DC, Lauritano AA, Tamborlane WV. Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med. 1986;315(4):215-9. (Pubitemid 16097122)
20. Koltin D, Daneman D. Dead-in-bed syndrome - a diabetes nightmare. Pediatr Diabetes. 2008;9(5):504-7. Epub 2008 May 22.
21. Sovik O, Thordarson H. Dead-in-bed syndrome in young diabetic patients. Diabetes Care. 1999;22 Suppl 2:B40-2. (Pubitemid 29107147)
22. Redondo MJ, Kaminski BM, Block J, Buckingham B, Cengiz E, Haller M, Haymond M, Lee J, Schatz D, Silverstein J, Tamborlane W, Wood J, Klingensmith G, Pediatric Diabetes Consortium. BMI in children with autoimmune type 1 diabetes. Presented at: 37th Annual Meeting, International Society for Pediatric and Adolescent Diabetes, Miami Beach, FL, October 19-22, 2011.
23. Vaikom House AK, Havalad S, Quaid M, Tsifansky M, Angst D. Predictors of DKA-Associated Death in Children. Presented at: Pediatric Academic Societies Annual Meeting, Boston, MA, April 28-May 1, 2012.
24. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006;55(12):3344-50. (Pubitemid 44923591)
25. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008;31(5):934-9. Epub 2008 Feb 5.
26. Cengiz E, Tamborlane WV, Sherr JL, Martin-Fredericksen M, Aglio T, Weinzimer SA. Utilizing a Novel Infusion Site Warming Device to Quicken Insulin Action: the InsuPatch Project. Presented at: 71st Scientific Sessions (2011), American Diabetes Association, San Diego, CA, June 24-28, 2011.